ACN vs ALL Stock Comparison
Scores Breakdown
| Metric | ACN | ALL |
|---|---|---|
| 📈 Growth | 22/30 | 22/30 |
| 💰 Profitability | 18/20 | 14/20 |
| 🏦 Financial Health | 18/20 | 18/20 |
| 💵 Valuation | 16/20 | 10/20 |
| ⚠️ Risk (lower is better) | 4/10 | 6/10 |
| Overall Score | 80/100 | 68/100 |
Side-by-Side Summaries
| ACN Analysis | ALL Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, revenues moved from $16.41B (2024 Q4) to $18.72B (2026 Q3), a cumulative rise of about 14%. Net income increased from roughly $1.68B to $2.34B, up about 39%, signaling improving operating leverage as scale widens. The trend shows quarterly fluctuations but an overall positive trajectory with gradually rising profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryAcross 8 quarters, Allstate’s revenue rose from about $15.714B (2024-Q2) to about $16.941B (2026-Q1), up roughly 7.8%. Net income climbed from about $0.347B to $2.458B, a multi‑fold increase, with a notable surge in late‑2025 before a softer start in 2026. The trend is positive overall but shows quarterly volatility (e.g., 2025‑Q1 dip followed by stronger 2025‑Q3/Q4). End‑period profitability remains sensitive to cost structure and mix, yet margins improved from multi‑quarter lows to mid‑teens late in 2025 and into 2026. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|